These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 22718512)
1. Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis. Shi KQ; Fan YC; Liu WY; Li LF; Chen YP; Zheng MH Mol Biol Rep; 2012 Oct; 39(10):9715-22. PubMed ID: 22718512 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of traditional Chinese medicine combined with Silibinin on nonalcoholic fatty liver disease: A meta-analysis and systematic review. Zhang X; Jiang Z; Jin X; Zhou Q Medicine (Baltimore); 2024 Feb; 103(5):e37052. PubMed ID: 38306552 [TBL] [Abstract][Full Text] [Related]
3. Herbal medicines for fatty liver diseases. Liu ZL; Xie LZ; Zhu J; Li GQ; Grant SJ; Liu JP Cochrane Database Syst Rev; 2013 Aug; (8):CD009059. PubMed ID: 23975682 [TBL] [Abstract][Full Text] [Related]
4. Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress. Gong P; Long H; Guo Y; Wang Z; Yao W; Wang J; Yang W; Li N; Xie J; Chen F J Ethnopharmacol; 2024 Jan; 318(Pt B):116927. PubMed ID: 37532073 [TBL] [Abstract][Full Text] [Related]
5. Xuefu Zhuyu decoction for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis. Liu J; Dong B; Yang L; Huang W; Tang S Medicine (Baltimore); 2021 May; 100(19):e25358. PubMed ID: 34106587 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of traditional herbal medicine in the treatment of nonalcoholic fatty liver disease. Peng H; He Y; Zheng G; Zhang W; Yao Z; Xie W Cell Mol Biol (Noisy-le-grand); 2016 Apr; 62(4):88-95. PubMed ID: 27188741 [TBL] [Abstract][Full Text] [Related]
7. Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease. Dong H; Lu FE; Zhao L Chin J Integr Med; 2012 Feb; 18(2):152-60. PubMed ID: 22311412 [TBL] [Abstract][Full Text] [Related]
8. Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease. Zhou H; Ma C; Wang C; Gong L; Zhang Y; Li Y Eur J Pharmacol; 2021 May; 898():173976. PubMed ID: 33639194 [TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence. Tang JT; Mao YM J Dig Dis; 2017 Nov; 18(11):607-617. PubMed ID: 29106066 [TBL] [Abstract][Full Text] [Related]
10. Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine. Zhou Z; Zhang J; You L; Wang T; Wang K; Wang L; Kong X; Gao Y; Sun X Front Endocrinol (Lausanne); 2022; 13():1000727. PubMed ID: 36204095 [TBL] [Abstract][Full Text] [Related]
11. Compound Formulas of Traditional Chinese Medicine for the Common Cold: Systematic Review of Randomized, Placebo-controlled Trials. Li G; Cai L; Jiang H; Dong S; Fan T; Liu W; Xie L; Mao B Altern Ther Health Med; 2015; 21(6):48-57. PubMed ID: 26567449 [TBL] [Abstract][Full Text] [Related]
12. Chinese medicine formulas for nonalcoholic fatty liver disease: Overview of systematic reviews. Dai L; Zhou WJ; Zhong LLD; Tang XD; Ji G World J Clin Cases; 2021 Jan; 9(1):102-117. PubMed ID: 33511176 [TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of Chinese herbal medicine, Rhodiola formulation in treating ischemic heart disease: a systematic review and meta-analysis of randomized controlled trials. Yu L; Qin Y; Wang Q; Zhang L; Liu Y; Wang T; Huang L; Wu L; Xiong H Complement Ther Med; 2014 Aug; 22(4):814-25. PubMed ID: 25146085 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials. Liang Z; Chen X; Shi J; Hu H; Xue Y; Ung COL Chin Med; 2021 Jan; 16(1):9. PubMed ID: 33430929 [TBL] [Abstract][Full Text] [Related]
15. [Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis]. Liu HM; Wang XB; Chang YJ; Gu LL Zhong Xi Yi Jie He Xue Bao; 2012 Nov; 10(11):1211-28. PubMed ID: 23158939 [TBL] [Abstract][Full Text] [Related]
16. Oral traditional Chinese medication for adhesive small bowel obstruction. Suo T; Gu X; Andersson R; Ma H; Zhang W; Deng W; Zhang B; Cai D; Qin X Cochrane Database Syst Rev; 2012 May; (5):CD008836. PubMed ID: 22592734 [TBL] [Abstract][Full Text] [Related]
17. Traditional chinese medicine for the treatment of chronic prostatitis in China: a systematic review and meta-analysis. Chen JX; Hu LS J Altern Complement Med; 2006 Oct; 12(8):763-9. PubMed ID: 17034282 [TBL] [Abstract][Full Text] [Related]
18. Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease: an update. Musso G; Cassader M; Gambino R Curr Opin Lipidol; 2011 Dec; 22(6):489-96. PubMed ID: 21986643 [TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Musso G; Gambino R; Cassader M; Pagano G Hepatology; 2010 Jul; 52(1):79-104. PubMed ID: 20578268 [TBL] [Abstract][Full Text] [Related]
20. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]